Collagen Loss in Menopause: Evidence-Based Treatments That Actually Work
The market is full of collagen-boosting claims. A physician cuts through the noise to identify which treatments have genuine evidence behind them — and which are simply well-marketed wishful thinking.
This content is for informational purposes only and does not constitute medical advice. Please consult your physician before starting any treatment programme.
If you search "boost collagen menopause" you will find thousands of products, hundreds of claims, and remarkably little that is grounded in clinical evidence. This is a problem, because collagen loss during menopause is real, significant, and worth addressing — with the right tools.
At London & Glow, every treatment recommendation is rooted in the evidence. This article is my attempt to give you the same clarity I provide in the consultation room: what works, what has weak evidence, and what is simply unsupported marketing.
The Scale of the Problem
To understand why treatment matters, it helps to understand the magnitude of collagen loss at menopause. Multiple biopsy-based studies have documented approximately 30% collagen loss in the first five years after menopause — driven by the withdrawal of oestrogen, which directly regulates fibroblast activity and collagen synthesis. After this initial rapid loss, collagen continues to decline at around 2% per year.
The clinical consequences are not subtle: skin thinning, increased laxity, deepening of lines, hollowing of the face, and loss of the plump, resilient quality that healthy collagen provides. These are structural changes, not surface-level issues.
Tier 1: Strong Evidence
Polynucleotides (PDRN)
Polynucleotides are fragments of purified DNA that act as biostimulants — they stimulate fibroblast activity, directly increasing collagen and elastin synthesis. Multiple randomised controlled trials and cohort studies demonstrate measurable improvements in skin elasticity, thickness, and hydration following a course of polynucleotide injections. They also have documented anti-inflammatory properties, which is particularly relevant for hormonally sensitised menopausal skin.
Polynucleotides work over 4–8 weeks as tissue remodelling occurs. A course of 3–4 sessions is typically recommended. They do not provide immediate visible results in the way that fillers do — the improvement is genuine tissue regeneration, which takes time.
Evidence grade: Strong
Microneedling (Collagen Induction Therapy)
Microneedling's mechanism is well-established: controlled micro-injuries trigger a wound-healing cascade that drives new collagen (Types I and III) and elastin synthesis. The evidence base is robust — multiple systematic reviews and meta-analyses demonstrate significant improvements in collagen density and skin texture following courses of microneedling, with histological confirmation.
For menopausal skin specifically, the collagen stimulus provided by microneedling is particularly valuable because it partially compensates for the reduced fibroblast activity caused by oestrogen decline. Results continue to improve for up to 6 months as new collagen matures.
Evidence grade: Strong
Prescription Tretinoin (Topical Retinoid)
Prescription-strength vitamin A (tretinoin) is one of the most extensively studied topical interventions for collagen. It stimulates fibroblasts, increases Type I procollagen synthesis, and inhibits collagen-degrading matrix metalloproteinases. Multiple randomised controlled trials confirm clinically measurable collagen increases with consistent use.
The caveat: tretinoin must be prescribed and managed by a physician. On menopausal skin, it requires careful titration — too much, too fast causes irritation that can compromise the barrier and set back progress. Over-the-counter retinols are less potent but better tolerated; they work via the same pathway but more slowly.
Evidence grade: Strong (prescription); Good (OTC retinol)
Tier 2: Good Evidence
PRP (Platelet-Rich Plasma)
PRP concentrates the patient's own platelets, which are rich in growth factors (PDGF, TGF-β, VEGF, EGF) that stimulate fibroblast activity and collagen production. The evidence is more variable than for polynucleotides or microneedling — study quality and platelet concentration protocols vary considerably — but multiple well-conducted studies demonstrate meaningful improvements in skin quality, hydration, and texture.
Combined PRP + microneedling appears to have additive effects, and this combination is increasingly supported in the literature.
Evidence grade: Good (with caveats around study quality)
Skin Boosters (Stabilised Hyaluronic Acid)
Skin boosters (such as Restylane Skinboosters or Juvederm Volite) work differently from fillers — they are not placed to add volume but injected diffusely into the dermis to restore moisture content and provide a substrate for collagen function. While their primary mechanism is hydration, some formulations contain cross-linked HA that stimulates fibroblast activity, and clinical studies demonstrate improvements in skin elasticity and quality.
They do not directly stimulate new collagen synthesis in the way polynucleotides or microneedling do, but they support the hydration environment in which collagen fibres function optimally.
Evidence grade: Good
What Doesn't Make the List
Collagen Supplements
Oral collagen hydrolysates have attracted significant research interest. A 2019 systematic review in the Journal of Drugs in Dermatology found modest improvements in skin hydration and elasticity in some studies, but the effect sizes were small and the evidence base is inconsistent. The theoretical concern — that collagen proteins are broken down in the gut before reaching the skin — may be addressed by the action of bioactive peptides from collagen digestion, but this pathway remains incompletely characterised.
Evidence grade: Weak to moderate — potentially supportive but not a treatment
Collagen Creams
Collagen molecules in topical products are too large to penetrate the skin barrier meaningfully. They function as occlusives — sealing moisture in — which is useful, but they do not add collagen to the dermis. The marketing language around "collagen-boosting creams" is overwhelmingly unsupported.
Evidence grade: Not applicable (mechanism does not support claims)
Building a Collagen Programme
For my patients at London & Glow who want to address menopause-related collagen loss systematically, a typical programme might include:
- Prescription or high-quality OTC retinoid, used consistently at home
- A course of polynucleotides or microneedling (or both, depending on budget and goals)
- Skin boosters for hydration support
- SPF 50+ daily (UV accelerates collagen degradation via MMP upregulation)
- Vitamin C serum (a collagen co-factor)
The most important insight is that no single intervention does it all. The combination of a home retinoid routine, regular in-clinic collagen stimulation, and rigorous sun protection produces results that dwarf any individual component.
References
- Rzepecki AK, et al. (2019). Estrogen-deficient skin: The role of topical therapy. Menopause Review, 18(1):57–65.
- Alam M, et al. (2018). Oral collagen supplementation: A systematic review. Journal of Drugs in Dermatology, 18(1):9–16.
- Dogra S, et al. (2014). Microneedling for acne scars in Asian skin type. Journal of Cutaneous and Aesthetic Surgery, 7(2):93–7.
- Kafi R, et al. (2007). Improvement of naturally aged skin with vitamin A (retinol). Archives of Dermatology, 143(5):606–12.